DK82798A - Treatment of GABA-uptake related disorders - Google Patents

Treatment of GABA-uptake related disorders

Info

Publication number
DK82798A
DK82798A DK82798A DK82798A DK82798A DK 82798 A DK82798 A DK 82798A DK 82798 A DK82798 A DK 82798A DK 82798 A DK82798 A DK 82798A DK 82798 A DK82798 A DK 82798A
Authority
DK
Denmark
Prior art keywords
gaba
treatment
related disorders
uptake related
uptake
Prior art date
Application number
DK82798A
Other languages
Danish (da)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK82798A priority Critical patent/DK82798A/en
Publication of DK82798A publication Critical patent/DK82798A/en

Links

DK82798A 1998-05-28 1998-05-28 Treatment of GABA-uptake related disorders DK82798A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK82798A DK82798A (en) 1998-05-28 1998-05-28 Treatment of GABA-uptake related disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK82798A DK82798A (en) 1998-05-28 1998-05-28 Treatment of GABA-uptake related disorders

Publications (1)

Publication Number Publication Date
DK82798A true DK82798A (en) 1998-05-28

Family

ID=8098003

Family Applications (1)

Application Number Title Priority Date Filing Date
DK82798A DK82798A (en) 1998-05-28 1998-05-28 Treatment of GABA-uptake related disorders

Country Status (1)

Country Link
DK (1) DK82798A (en)

Similar Documents

Publication Publication Date Title
CY2018020I1 (en) TREATMENT OF ROMRE'S DISEASE
NO993051D0 (en) Intranasal formulations for the treatment of sexual disorders
DE69925306D1 (en) TREATMENT OF HYDROCARBONGAS
ID25792A (en) ANTIBODIES OF HUMAN CD40
ID27841A (en) THERAPEUTIC BIARILS
DE69936335D1 (en) USE OF MORPHOLINOL FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISORDERS
DK1063990T3 (en) Use of Biochanine-Enriched Extract for the Treatment of Estrogen-Associated Disorders
PT1077940E (en) 4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURIGINAL DERMATOSES
ID27191A (en) METHODS FOR TREATMENT OF INSOMNIA
DE69921571D1 (en) MASSAGER
NO20005179D0 (en) Drug treatment
NO20020062L (en) Treatment of neurotic disorders
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
IS5951A (en) 5HT1 antidepressant for the treatment of depression
NO20012106L (en) Means for the treatment of disorders of bone metabolism
ID28032A (en) TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2
ATE230741T1 (en) 3-TETRAHYDROPYRIDINE-4-YL-INDOLE FOR THE TREATMENT OF PSYCHOTIC DISORDERS
NO20010390D0 (en) Treatment of anxiety disorders
NO20012612D0 (en) Isonipecotamides for the treatment of integrin-mediated disorders
ID30458A (en) OSANETAN IN TREATMENT OF SOUL DISORDERS
AR026062A1 (en) TREATMENT OF EYE DISORDERS
PT1200447E (en) OXAZINOCARBAZOLES FOR THE TREATMENT OF DISEASES OF THE SNC
EE200200670A (en) S-methyldihydroziprasidone for the treatment of psychiatric and ocular disorders
IL126681A0 (en) Treatment of trauma-related conditions
NO20006383L (en) Process of treatment